297 related articles for article (PubMed ID: 22521342)
21. Alterations of the bile microbiome in primary sclerosing cholangitis.
Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
[TBL] [Abstract][Full Text] [Related]
22. Immunogenetics in primary sclerosing cholangitis.
Chung BK; Hirschfield GM
Curr Opin Gastroenterol; 2017 Mar; 33(2):93-98. PubMed ID: 28146446
[TBL] [Abstract][Full Text] [Related]
23. Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis.
Wannhoff A; Rupp C; Friedrich K; Brune M; Knierim J; Flechtenmacher C; Sauer P; Stremmel W; Hov JR; Schirmacher P; Weiss KH; Gotthardt DN
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2372-9. PubMed ID: 26192140
[TBL] [Abstract][Full Text] [Related]
24. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW;
Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
[TBL] [Abstract][Full Text] [Related]
26. Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice.
Maroni L; Hohenester SD; van de Graaf SFJ; Tolenaars D; van Lienden K; Verheij J; Marzioni M; Karlsen TH; Oude Elferink RPJ; Beuers U
Hepatology; 2017 Aug; 66(2):542-554. PubMed ID: 28056490
[TBL] [Abstract][Full Text] [Related]
27. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
[TBL] [Abstract][Full Text] [Related]
28. A lecture on the genetics of primary sclerosing cholangitis.
Karlsen TH
Dig Dis; 2012; 30 Suppl 1():32-8. PubMed ID: 23075866
[TBL] [Abstract][Full Text] [Related]
29. Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis.
Pratt HE; Wu T; Elhajjajy S; Zhou J; Fitzgerald K; Fazzio T; Weng Z; Pratt DS
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756045
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
Ji SG; Juran BD; Mucha S; Folseraas T; Jostins L; Melum E; Kumasaka N; Atkinson EJ; Schlicht EM; Liu JZ; Shah T; Gutierrez-Achury J; Boberg KM; Bergquist A; Vermeire S; Eksteen B; Durie PR; Farkkila M; Müller T; Schramm C; Sterneck M; Weismüller TJ; Gotthardt DN; Ellinghaus D; Braun F; Teufel A; Laudes M; Lieb W; Jacobs G; Beuers U; Weersma RK; Wijmenga C; Marschall HU; Milkiewicz P; Pares A; Kontula K; Chazouillères O; Invernizzi P; Goode E; Spiess K; Moore C; Sambrook J; Ouwehand WH; Roberts DJ; Danesh J; Floreani A; Gulamhusein AF; Eaton JE; Schreiber S; Coltescu C; Bowlus CL; Luketic VA; Odin JA; Chopra KB; Kowdley KV; Chalasani N; Manns MP; Srivastava B; Mells G; Sandford RN; Alexander G; Gaffney DJ; Chapman RW; Hirschfield GM; de Andrade M; ; ; ; Rushbrook SM; Franke A; Karlsen TH; Lazaridis KN; Anderson CA
Nat Genet; 2017 Feb; 49(2):269-273. PubMed ID: 27992413
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
32. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
34. Combinations of FUT2 gene polymorphisms and environmental factors are associated with oral cancer risk.
Su KJ; Ho CC; Lin CW; Chen MK; Su SC; Yu YL; Yang SF
Tumour Biol; 2016 May; 37(5):6647-52. PubMed ID: 26646561
[TBL] [Abstract][Full Text] [Related]
35. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.
Gaj P; Habior A; Mikula M; Ostrowski J
BMC Med Genet; 2008 Aug; 9():81. PubMed ID: 18715515
[TBL] [Abstract][Full Text] [Related]
36. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
37. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
38. Genetics in PSC: what do the "risk genes" teach us?
Folseraas T; Liaskou E; Anderson CA; Karlsen TH
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):154-64. PubMed ID: 24736995
[TBL] [Abstract][Full Text] [Related]
39. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
[TBL] [Abstract][Full Text] [Related]
40. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
